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Imaging the immune response
Y
ou can learn a lot from a picture. Case in 
point, a new report from Kamal Khanna, 
Jeffrey McNamara, and Leo Lefrançois 
(University of Connecticut, Farmington, CT) images 
T cells as they prepare to fi  ght infection.
To examine the cell dynamics of an immune 
response, the researchers used laser scanning 
microscopy to take 3D snapshots of T cells in the 
spleen during infection. The authors infected 
mice with Listeria monocytogenes that expressed 
a well-studied antigen, ovalbumin. They then 
examined the animals’ spleens at different times, 
staining for T cells (of the CD8+ T cell subtype) 
that could recognize and kill cells expressing 
ovalbumin antigens.
Immune responses can be initiated in the spleen, 
which is subdivided into compartments containing 
different kinds of immune cells; upon infection, the 
authors saw increased movements of T cells between 
certain compartments. Initiation of the immune 
response in the spleen appeared to take place within 
the lymphocyte-containing white pulp, at the border 
between B cell–rich areas and a T cell–rich area 
known as PALS. What is so special about this zone 
that drives the immune response will have to be 
addressed in future studies.
Later during infection, T cells moved between 
the white pulp and red blood cell–rich red pulp areas 
of the spleen via structures called bridging channels. 
Only once they made it to the red pulp did the T cells 
have access to the circulation and travel to the rest 
of the body to fi  ght infection.
After infection was resolved, memory T cells 
(those that had seen the antigen) were found in 
both the red pulp and B cell areas of the spleen. 
When animals were 
challenged with a sec-
ond infection, memory 
T cells moved from the 
B cell area to the PALS 
and commenced later 
steps in the response. 
“For a CD8+ T cell, it 
was rather bizarre to 
find them in the B cell 
areas,” says Lefrançois. 
“We’re still trying to 
understand the func-
tional signifi  cance.”
Reference: Khanna, K.M., 
et al. 2007. Science. 
318:116–120.
T
umors that escape from their original site are associ-
ated with a poor prognosis for cancer patients. New 
research by Antoine Karnoub, Robert Weinberg 
(Whitehead Institute, Cambridge, MA), and colleagues sug-
gests that the ability to escape may be acquired through the 
tumor’s interactions with normal tissues.
A growing tumor is considered by its surrounding normal 
tissue to be a bit like a wound. As also occurs during the wound 
response, tumors recruit mesenchymal stem cells (MSCs)—which 
are meant to help with repair—from the bone marrow. Karnoub 
et al. hypothesized that these MSCs, rather than being helpful, 
may instead advance disease. To investigate this idea, they 
injected human breast cancer cells, either alone or along with 
human MSCs, into mice and then looked for metastases in the 
animals’ lungs.
When MSCs were mixed with tumors, several cancer cell 
lines were more metastatic. This behavior was reversible; MSC-
induced metastases puriﬁ  ed from one animal and then injected 
without MSCs into new animals were no more metastatic than 
the original primary tumors. MSCs thus seem to teach cancer 
cells tricks that are not intrinsic to the cancer itself.
Some of these tricks might be learned from MSC-derived 
chemokines. The MSCs provided two lines of breast cancer cells 
with the chemokine CCL5, which caused the tumor cells to become 
more motile and invasive. MSCs had to contact cancer cells to 
make CCL5, but it is not known what interactions are important. 
And not every cancer line stimulated CCL5 production. “I liken it to 
a key-and-lock situation,” says Karnoub. ”The cancer has the key, 
but what lock it ﬁ  ts to release CCL5 from MSCs is a mystery.”
Karnoub is also interested in how cancer cells cause long-
term changes in MSC behavior. “The MSCs remembered 
having been in contact with tumor cells; even three days or 
more after their initial exposure, they were still making CCL5. 
There’s a two-way communication going on there.”
Reference: Karnoub, A., et al. 2007. Nature. 449:557–565.
Antigen-activated T cells (red) can be spied going 
from place to place within the spleen.
Breast cancer cells (green) are more likely to metastasize to the lung if 
MSCs are around (right) to enhance their invasive ability.
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